Trial Profile
The Use of Entanercept (Enbrel) as Sole Treatment for Grade I Acute Graft Versus Host Disease.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Jan 2019
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 04 Jan 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 22 Aug 2013 Planned End Date changed from 1 Jun 2015 to 1 Jun 2014 as reported by ClinicalTrials.gov.
- 22 Aug 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.